Cancer Treatment News and Research

RSS

Proton therapy used for the first time in Switzerland to treat lung cancer

Today a 60-year-old patient suffering from lung cancer received proton beam therapy, a medical procedure where positively charged particles are precisely targeted at the tumor. This is the first time this type of radiotherapy has been used for lung cancer treatment in Switzerland.

9 Nov 2021

Researchers develop model for early prediction of cancer patients' response to immunotherapy

Researchers have developed a model that could predict early on in treatment whether cancer patients will respond to immunotherapy, according to a report published today in eLife.

9 Nov 2021

Researchers identify safety concerns with neuroblastoma candidate drug

St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461.

9 Nov 2021

Fat-secreted molecule may cancel out the effects of common breast cancer treatment

Leptin, a molecule produced by fat cells, appears to cancel out the effects of the estrogen-blocking therapy tamoxifen, a drug commonly used to treat and prevent breast cancers, suggests a new study led by researchers from the Johns Hopkins Kimmel Cancer Center.

9 Nov 2021

Experts discover novel tool to explore ways to advance cancer treatment

Researchers at Queen’s University Belfast have discovered a new tool, which will help to investigate more effective forms of cancer treatment.

9 Nov 2021

Novel study aims to develop personalized treatment for triple-negative breast cancer

Indiana University School of Medicine researcher Bryan P. Schneider, MD, is leading a novel nationwide study to better understand how to treat patients with triple-negative breast cancer based on their own unique genetic data.

8 Nov 2021

Experts reveal improved survival for patients with two out of three types of advanced breast cancer

Patients with two out of the three most common types of advanced breast cancer now have an average survival time of at least five years, according to a panel of experts at the Advanced Breast Cancer Sixth International Consensus Conference (ABC 6).

7 Nov 2021

How does a surgeon’s language affect patient risk perception?

In this interview, we speak to Dr. Joshua E. Rosen about his latest research into treatment options and what role a surgeon’s language plays in people's perception of its risks.

4 Nov 2021

Harvard researchers elucidate the underlying neuroanatomy of acupuncture

Acupuncture is a traditional Chinese technique that has been used for millennia to treat chronic pain and other health problems associated with inflammation, yet the scientific basis of the technique remains poorly understood.

2 Nov 2021

Two new studies show how to enhance effectiveness of cancer immunotherapy

Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell carcinoma (OCSCC) and identified potential molecular biomarkers in the blood and tumors of patients that would show how likely it is that someone would respond to immunotherapy.

30 Oct 2021

Chromosome aberrations linked to acute toxicities in esophageal cancer patients

Japanese researchers identified chromosome aberrations as a new biomarker in predicting an esophageal cancer patient's risk of experiencing severe chemoradiotherapy side effects.

28 Oct 2021

A new approach to selectively turn on gene therapies in target cells

Researchers at MIT and Harvard University have designed a way to selectively turn on gene therapies in target cells, including human cells.

28 Oct 2021

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

Researchers at the Francis Crick Institute, The Royal Marsden NHS Foundation Trust and UCL have found immune cell patterns within tumors that can help predict if patients with kidney cancer will respond to immunotherapy.

28 Oct 2021

New system created for targeted delivery of anti-cancer drugs

RUDN University and Shahid Beheshti University (SBU) chemist together with colleagues from Iran created a system for targeted delivery of anti-cancer drugs.

27 Oct 2021

Study finds disparities in dissemination of cancer survivorship care plans

Survivorship care plans are an important tool to help cancer survivors transition out of active treatment and back to their regular lives, but a new study found that a number of vulnerable groups are not receiving those plans.

27 Oct 2021

Protein plays a previously unknown role in halting cell cycle in response to stressful conditions

UT Southwestern researchers have identified a new mechanism by which stress causes cells to stop dividing.

27 Oct 2021

Lung cancer-associated fibroblasts could guide the design of personalized treatments

Three subtypes of cancer-associated fibroblasts (CAF) could guide the design of personalized treatment for lung cancer patients, according to a new study in Cancer Cell led by researchers at Massachusetts General Hospital.

26 Oct 2021

Intervention erases Black-white survival gaps in early-stage lung and breast cancer patients

A new study shows that system-level changes to the way cancer care is delivered can also eliminate Black-white disparities in survival from early-stage lung and breast cancer.

25 Oct 2021

Study looks at effectiveness and ethics of financial incentives for low-risk clinical trials

Use of financial incentives in two low-risk randomized clinical trials did not present ethical issues, and in one of the trials, the incentives increased study participation, according to findings published in JAMA Internal Medicine.

25 Oct 2021

Study provides a specific target to tackle breast cancer relapse

Molecular targets for therapies that could prevent breast cancer recurrence have been identified by a group of German, Norwegian and British scientists who analyzed tumour cells that proved resistant to the original treatment.

25 Oct 2021

Cancer Treatment News and Research

Proton therapy used for the first time in Switzerland to treat lung cancer

Researchers develop model for early prediction of cancer patients' response to immunotherapy

Researchers identify safety concerns with neuroblastoma candidate drug

Fat-secreted molecule may cancel out the effects of common breast cancer treatment

Experts discover novel tool to explore ways to advance cancer treatment

Novel study aims to develop personalized treatment for triple-negative breast cancer

Experts reveal improved survival for patients with two out of three types of advanced breast cancer

How does a surgeon’s language affect patient risk perception?

Harvard researchers elucidate the underlying neuroanatomy of acupuncture

Two new studies show how to enhance effectiveness of cancer immunotherapy

Chromosome aberrations linked to acute toxicities in esophageal cancer patients

A new approach to selectively turn on gene therapies in target cells

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

New system created for targeted delivery of anti-cancer drugs

Study finds disparities in dissemination of cancer survivorship care plans

Protein plays a previously unknown role in halting cell cycle in response to stressful conditions

Lung cancer-associated fibroblasts could guide the design of personalized treatments

Intervention erases Black-white survival gaps in early-stage lung and breast cancer patients

Study looks at effectiveness and ethics of financial incentives for low-risk clinical trials

Study provides a specific target to tackle breast cancer relapse

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News